I. Louviaux

发表

European Lung Cancer Working Party Clinical Practice Guidelines. Non-Small Cell Lung Cancer: III. Metastatic disease

J. Lafitte, P. Houtte, M. Paesmans, 2006 .

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis.

M. Paesmans, T. Berghmans, C. Mascaux, 2002, Lung cancer.

European Lung Cancer Working Party Clinical Practice Guidelines Non-small Cell Lung Cancer: II. Unresectable Non-metastatic Stages

J. Lafitte, V. Ninane, C. Mascaux, 2006 .

European Lung Cancer Working Party Clinical Practice Guidelines. Small cell lung cancer: IV. Limited disease.

J. Lafitte, P. Houtte, M. Paesmans, 2007 .

European Lung Cancer Working Party Clinical Practice Guidelines. Small cell lung cancer: V. Extensive diseases.

J. Lafitte, P. Houtte, P. Wackenier, 2007 .

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

J. Machiels, G. Berchem, A. van Maanen, 2015, The oncologist.

Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma

E. Coche, A. Delannoy, L. Michaux, 2000, Leukemia.

Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2‐chloro‐2′‐deoxyadenosine

A. Hagemeijer, A. Delannoy, L. Michaux, 1999, British journal of haematology.

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future

E. de Azambuja, A. Laenen, M. Brandão, 2022, ESMO Open.

Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2′-deoxyadenosine

V. Deneys, F. Bontemps, A. Ferrant, 1999, Leukemia.

Digital clubbing in a patient with progressive mantle cell lymphoma

L. Michaux, A. Ferrant, N. Straetmans, 1999, Annals of Hematology.

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations

J. Lafitte, P. V. Van Schil, P. van Houtte, 2011, European Respiratory Journal.

European Lung Cancer Working Party Clinical Practice Guidelines. Non-small cell lung cancer: I. Early stages

J. Lafitte, V. Ninane, T. Berghmans, 2006 .

Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia

J. Body, J. Dumon, I. Louviaux, 1998, Supportive Care in Cancer.

European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease

J. Lafitte, P. Houtte, T. Berghmans, 2007 .